Publications by authors named "J Matschke"

We report here on a patient with concomitant indolent lymphoma who showed a rapid progressive deterioration of his general condition and emerging neurological symptoms. The combination of severe B symptoms with hypermetabolic involvement of the adrenal glands and multiple central nervous system (CNS) lesions initially suggested a malignant disease. However, when the patient presented to us with biopsy results from one of the CNS lesions, the biopsy revealed granulomatous inflammation but no evidence of malignancy.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the impact of presurgical tumor growth and other clinical factors on the survival of glioblastoma (GBM) patients.
  • A retrospective analysis of 98 adult GBM patients revealed that tumor growth rates did not significantly affect overall survival (OS) or progression-free survival (PFS).
  • Key predictors of treatment outcomes included MGMT status, radiation dose, and the number of adjuvant cycles of temozolomide (TMZ), which can help inform personalized treatment plans.
View Article and Find Full Text PDF

Background: Radiation science is of utmost significance not only due to its growing importance for clinical use, but also in everyday life such as in radiation protection questions. The expected increase in cancer incidence due to an aging population combined with technical advancements further implicates this importance and results in a higher need for sufficient highly educated and motivated personnel. Thus, factors preventing young scientists and medical personnel from entering or remaining in the field need to be identified.

View Article and Find Full Text PDF

Anti-IgLON5 disease is a unique condition that bridges autoimmunity and neurodegeneration. Since its initial description 10 years ago, an increasing number of autopsies has led to the observation of a broader spectrum of neuropathologies underlying a particular constellation of clinical symptoms. In this study, we describe the neuropathological findings in 22 patients with anti-IgLON5 disease from 9 different European centers.

View Article and Find Full Text PDF